Windlas Biotech Q3 Results
- BSE: 543329
- NSE: WINDLAS
- ISIN: INE0H5O01029
- Sector: Biotechnology & Drugs
BSE
804.40
7.35 (0.92%)
7.35 (0.92%)Volume1.66 K
Updated: Fri 13 Feb, 2026 | 15:28:00
NSE
804.907.10 (0.89%)
7.10 (0.89%)Volume39.09 K
Updated: Fri 13 Feb, 2026 | 15:41:11
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
- Total Income₹233.10 Cr.(19.53%)
- Operating Profit₹16.68 Cr.(-5.73%)
- Profit After Tax₹15.00 Cr.(-3.69%)
- Operating Margin7.15%(-21.13%)
Note: Comparison is on YoY basis
Quarterly - Windlas Biotech Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 216.42 | 170.45 | 7.44% | 145.27 | 22.05% |
| Depreciation/ Amortization | 7.70 | 6.50 | 1.34% | 3.39 | 10.95% |
| Operating Income | 16.68 | 16.55 | -20.43% | 16.95 | -5.73% |
| Net Income | 15.00 | 15.66 | -15.72% | 15.10 | -3.69% |
| Other Operating Expenses Total | 23.18 | 16.56 | 13.36% | 17.50 | 33.31% |
| Net Income Before Taxes | 19.97 | 20.29 | -15.33% | 19.81 | -1.80% |
| Total Revenue | 233.10 | 187.00 | 4.81% | 162.21 | 19.53% |
| Selling/ General/ Admin Expenses Total | 42.05 | 30.97 | 15.37% | 22.73 | 30.70% |
| Diluted Normalized EPS | 7.05 | 7.43 | -16.07% | 7.26 | -4.47% |